← Evidence map

ArticleTheranostics2025

An AIM2 inflammasome biomimetic mineralization inhibitor for vascular dementia therapy.

Yueqi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40521199